NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) Fundamental Analysis & Valuation

TSX:NWH-DB-H • CA667495AJ41

Current stock price

100.7 CAD
-0.05 (-0.05%)
Last:

This NWH-DB-H.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. NWH-DB-H.CA Profitability Analysis

1.1 Basic Checks

  • NWH-DB-H had negative earnings in the past year.
  • In the past year NWH-DB-H had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NWH-DB-H reported negative net income in multiple years.
  • NWH-DB-H had a positive operating cash flow in each of the past 5 years.
NWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • NWH-DB-H has a Return On Assets of -1.53%. This is in the lower half of the industry: NWH-DB-H underperforms 60.00% of its industry peers.
  • The Return On Equity of NWH-DB-H (-3.51%) is worse than 60.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 6.96%, NWH-DB-H belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NWH-DB-H is in line with the industry average of 5.56%.
  • The last Return On Invested Capital (6.96%) for NWH-DB-H is above the 3 year average (4.86%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.53%
ROE -3.51%
ROIC 6.96%
ROA(3y)-3.68%
ROA(5y)-0.83%
ROE(3y)-13.37%
ROE(5y)-3.86%
ROIC(3y)4.86%
ROIC(5y)4.26%
NWH-DB-H.CA Yearly ROA, ROE, ROICNWH-DB-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • NWH-DB-H has a Operating Margin of 60.45%. This is in the better half of the industry: NWH-DB-H outperforms 77.14% of its industry peers.
  • NWH-DB-H's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 73.87%, NWH-DB-H is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • NWH-DB-H's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 60.45%
PM (TTM) N/A
GM 73.87%
OM growth 3Y-3.35%
OM growth 5Y-2.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.64%
GM growth 5Y-0.69%
NWH-DB-H.CA Yearly Profit, Operating, Gross MarginsNWH-DB-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NWH-DB-H.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NWH-DB-H is destroying value.
  • Compared to 1 year ago, NWH-DB-H has more shares outstanding
  • The number of shares outstanding for NWH-DB-H has been increased compared to 5 years ago.
  • NWH-DB-H has a better debt/assets ratio than last year.
NWH-DB-H.CA Yearly Shares OutstandingNWH-DB-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NWH-DB-H.CA Yearly Total Debt VS Total AssetsNWH-DB-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • NWH-DB-H has an Altman-Z score of 7.64. This indicates that NWH-DB-H is financially healthy and has little risk of bankruptcy at the moment.
  • NWH-DB-H has a Altman-Z score of 7.64. This is amongst the best in the industry. NWH-DB-H outperforms 97.14% of its industry peers.
  • The Debt to FCF ratio of NWH-DB-H is 9.19, which is on the high side as it means it would take NWH-DB-H, 9.19 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NWH-DB-H (9.19) is better than 88.57% of its industry peers.
  • A Debt/Equity ratio of 0.59 indicates that NWH-DB-H is somewhat dependend on debt financing.
  • NWH-DB-H's Debt to Equity ratio of 0.59 is amongst the best of the industry. NWH-DB-H outperforms 88.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 9.19
Altman-Z 7.64
ROIC/WACC0.9
WACC7.77%
NWH-DB-H.CA Yearly LT Debt VS Equity VS FCFNWH-DB-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.20 indicates that NWH-DB-H may have some problems paying its short term obligations.
  • NWH-DB-H has a worse Current ratio (0.20) than 60.00% of its industry peers.
  • NWH-DB-H has a Quick Ratio of 0.20. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of NWH-DB-H (0.20) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
NWH-DB-H.CA Yearly Current Assets VS Current LiabilitesNWH-DB-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NWH-DB-H.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.95% over the past year.
  • NWH-DB-H shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.10%.
  • NWH-DB-H shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.48% yearly.
EPS 1Y (TTM)84.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1184.73%
Revenue 1Y (TTM)-29.1%
Revenue growth 3Y-1.99%
Revenue growth 5Y2.48%
Sales Q2Q%4.76%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-H.CA Yearly Revenue VS EstimatesNWH-DB-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
NWH-DB-H.CA Yearly EPS VS EstimatesNWH-DB-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. NWH-DB-H.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NWH-DB-H. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NWH-DB-H.CA Price Earnings VS Forward Price EarningsNWH-DB-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • NWH-DB-H's Enterprise Value to EBITDA is on the same level as the industry average.
  • 85.71% of the companies in the same industry are cheaper than NWH-DB-H, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 168.81
EV/EBITDA 102.65
NWH-DB-H.CA Per share dataNWH-DB-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. NWH-DB-H.CA Dividend Analysis

5.1 Amount

  • NWH-DB-H has a Yearly Dividend Yield of 10.04%, which is a nice return.
  • NWH-DB-H's Dividend Yield is rather good when compared to the industry average which is at 7.24. NWH-DB-H pays more dividend than 91.43% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, NWH-DB-H pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

  • The dividend of NWH-DB-H decreases each year by -17.05%.
  • NWH-DB-H does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-17.05%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • NWH-DB-H has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-145.73%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-H.CA Yearly Income VS Free CF VS DividendNWH-DB-H.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

More info and screens

Find the best dividend stocksShow peers with best dividend

NWH-DB-H.CA Fundamentals: All Metrics, Ratios and Statistics

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-H (3/10/2026, 7:00:00 PM)

100.7

-0.05 (-0.05%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-25
Earnings (Next)05-12
Inst Owners10.74%
Inst Owner ChangeN/A
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap25.17B
Revenue(TTM)422.52M
Net Income(TTM)-52.85M
Analysts52.73
Price Target104.81 (4.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.31
Dividend Growth(5Y)-17.05%
DP-145.73%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.06%
PT rev (3m)-9.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 59.58
P/FCF 168.81
P/OCF 166.68
P/B 16.71
P/tB 16.71
EV/EBITDA 102.65
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.6
FCFY0.59%
OCF(TTM)0.6
OCFY0.6%
SpS1.69
BVpS6.03
TBVpS6.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -3.51%
ROCE 8.95%
ROIC 6.96%
ROICexc 7.2%
ROICexgc 7.21%
OM 60.45%
PM (TTM) N/A
GM 73.87%
FCFM 35.29%
ROA(3y)-3.68%
ROA(5y)-0.83%
ROE(3y)-13.37%
ROE(5y)-3.86%
ROIC(3y)4.86%
ROIC(5y)4.26%
ROICexc(3y)4.96%
ROICexc(5y)4.34%
ROICexgc(3y)5.01%
ROICexgc(5y)4.4%
ROCE(3y)6.24%
ROCE(5y)5.48%
ROICexgc growth 3Y26.73%
ROICexgc growth 5Y11.24%
ROICexc growth 3Y27.57%
ROICexc growth 5Y11.66%
OM growth 3Y-3.35%
OM growth 5Y-2.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.64%
GM growth 5Y-0.69%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 9.19
Debt/EBITDA 3.43
Cap/Depr 84.64%
Cap/Sales 0.45%
Interest Coverage 1.97
Cash Conversion 58.61%
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z 7.64
F-Score5
WACC7.77%
ROIC/WACC0.9
Cap/Depr(3y)38.8%
Cap/Depr(5y)39%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1184.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.1%
Revenue growth 3Y-1.99%
Revenue growth 5Y2.48%
Sales Q2Q%4.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.18%
EBIT growth 3Y-5.28%
EBIT growth 5Y-0.08%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.88%
FCF growth 3Y-12.63%
FCF growth 5Y-4.59%
OCF growth 1Y74.31%
OCF growth 3Y-12.34%
OCF growth 5Y-4.37%

NORTHWEST HEALTHCARE PRO / NWH-DB-H.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NWH-DB-H.CA.


Can you provide the valuation status for NORTHWEST HEALTHCARE PRO?

ChartMill assigns a valuation rating of 0 / 10 to NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA). This can be considered as Overvalued.


How profitable is NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) stock?

NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) has a profitability rating of 4 / 10.


Is the dividend of NORTHWEST HEALTHCARE PRO sustainable?

The dividend rating of NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) is 4 / 10 and the dividend payout ratio is -145.73%.